Tyromotion announces FDA Clearance and Listing of Lexo – The New Standard in Robotic, Gait Training

A leading manufacturer of technology-based therapeutic devices releases the seventh product of its Tyro Solution to improve the independence and quality of life for people around the globe.

Lexo, our newest lower extremity robot-assisted gait trainer, is now successfully listed with FDA and ready for sale in the USA. This now completes the Tyro Solution, providing the most complete offering for both upper and lower extremity products in the industry.

Lexo technology is based on the electromechanical end-effector principle, proven to be superior to other therapies. Numerous studies over the past 20 years demonstrate significantly better outcomes in walking, walking speed and overall strength in the lower extremities.

Setup time with Lexo is quick and easy and allows therapists to focus on the patient and actual therapy. Patients begin their therapy quickly, significantly reducing the therapist workload.

With Lexo, a wide range of patients with different levels of impairment can be treated and are motivated to reach their goals with various game-like exercises. Classic therapy and the latest technology have to be combined, creating a highly intensive, focused and motivating training environment.

This week we will attend the 14th International Society of Physical and Rehabilitation Medicine World Congress (ISPRM 2020) in Orlando, Florida – USA where our representatives will be available to discuss Lexo.

Host: Association of Academic Physiatrists (AAP) and International Society of Physical & Rehabilitation Medicine (ISPRM)

When: March 4-9, 2020

Where: Orlando, Florida

FOR FURTHER INFORMATION PLEASE VISIT:

https://www.physiatry.org/page/annualmeeting